|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2024
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/28797
Title: | Neuropsychiatric symptoms in Parkinson's disease |
Authors: | Loghin, Ana |
Issue Date: | 2024 |
Publisher: | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova |
Citation: | LOGHIN, Ana. Neuropsychiatric symptoms in Parkinson's disease. In: MedEspera: the 10th Intern. Medical Congress for Stud. and Young Doctors, 24-27 April 2024: abstract book. Chișinău, 2024, p. 392. ISBN 978-9975-3544-2-4. |
Abstract: | Introduction. BP is a major medical problem. According to World Health Organization (WHO)
data, the number of cases of Parkinson's disease is increasing. By 2030, the prevalence of
Parkinson's disease will exceed 9 million worldwide, making it one of the most common
neurological conditions with an increase in neuropsychiatric symptoms.
Aim of study. To identify neuropsychiatric symptoms in Parkinson's disease and assess the impact
of mental disorders on quality of life.
Methods and materials. In order to select the required publications, we accessed and explored
academic databases such as PubMed, Google Scholar, Science Direct, USMF "Nicolae
Testemitanu" scientific channels to ensure a comprehensive coverage of the existing literature and
consulted a wide range of sources including scientific articles, scholarly books and research
reports.
Results. Parkinson's disease is considered a multisystemic neurodegenerative disease, with
damage to various neurotransmitter systems and a wide range of motor and non-motor disorders
(neuropsychological, sensory, vegetative). Neuropsychiatric symptoms are quite common in
patients with Parkinson's disease: depression, apathy, anxiety, anhedonia, fatigue, cognitive
impairment, memory deficit, dementia, hallucinations, delusions, delirium, behavioral changes.
Autonomic nervous system dysfunctions affect about 70%-80% of patients with Parkinson's
disease and cause significant discomfort, leading to a decrease in both the quality and length of
patients' lives. Depression, anxiety and sleep disturbances can be early signs of the disease.
Depression occurs in 20-50% of patients, which exceeds the frequency of this disorder in the
population and in other chronic diseases. Depression is the factor most closely associated with
patients' poor quality of life indicators. Anxiety contributes to mental and somatic discomfort, as
well as worsening existing motor symptoms. Patients will report that anxiety worsens pre-existing
tremor or dyskinesia, and fear of falling has been associated with impaired postural stability.
Apathy is characterized by a lack of motivation, interest or desire to engage in activities or events
that previously would have been considered important or enjoyable. Cognitive impairments,
memory deficits, dementia, psychotic episodes negatively influence the quality of life and daily
functioning of patients with Parkinson's disease.
Conclusion. Neuropsychiatric manifestations play a major role in the quality of life of these
patients. As pathology progresses, quality of life decreases. Because many of the motor, non-motor
and psychiatric problems are interconnected, their optimal management requires coordination
between those providing neurological, psychiatric care, family support and social services. |
metadata.dc.relation.ispartof: | MedEspera: The 10th International Medical Congress for Students and Young Doctors, 24-27 April 2024, Chișinău, Republic of Moldova |
URI: | https://medespera.md/en/books?page=10 http://repository.usmf.md/handle/20.500.12710/28797 |
ISBN: | 978-9975-3544-2-4 |
Appears in Collections: | MedEspera 2024
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|